Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 11 | 2026 | 370 | 3.310 |
Why?
|
| Muscle, Skeletal | 13 | 2026 | 341 | 3.260 |
Why?
|
| Sarcoplasmic Reticulum | 5 | 2026 | 164 | 2.070 |
Why?
|
| Calcium Signaling | 6 | 2026 | 120 | 1.740 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 4 | 2026 | 141 | 1.620 |
Why?
|
| Muscle Fibers, Skeletal | 5 | 2025 | 45 | 1.420 |
Why?
|
| Muscular Diseases | 3 | 2026 | 17 | 1.290 |
Why?
|
| Calsequestrin | 5 | 2017 | 34 | 1.160 |
Why?
|
| Doxorubicin | 1 | 2026 | 60 | 0.940 |
Why?
|
| Oxidative Stress | 1 | 2026 | 83 | 0.940 |
Why?
|
| Blood Glucose | 2 | 2025 | 103 | 0.900 |
Why?
|
| Mice | 10 | 2026 | 1238 | 0.850 |
Why?
|
| Animals | 14 | 2026 | 3269 | 0.830 |
Why?
|
| Age Factors | 1 | 2025 | 636 | 0.780 |
Why?
|
| Muscle Proteins | 2 | 2022 | 25 | 0.750 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 8 | 0.750 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 52 | 0.730 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2022 | 17 | 0.730 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 43 | 0.720 |
Why?
|
| Malignant Hyperthermia | 4 | 2023 | 18 | 0.680 |
Why?
|
| Hyperglycemia | 3 | 2025 | 32 | 0.570 |
Why?
|
| Membrane Potentials | 2 | 2013 | 168 | 0.470 |
Why?
|
| Hypothermia | 1 | 2013 | 5 | 0.400 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 6 | 0.390 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 34 | 0.390 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 80 | 0.390 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2012 | 6 | 0.380 |
Why?
|
| Action Potentials | 3 | 2026 | 83 | 0.360 |
Why?
|
| Reactive Oxygen Species | 2 | 2026 | 102 | 0.270 |
Why?
|
| Glycogen | 2 | 2024 | 13 | 0.250 |
Why?
|
| Muscle Fatigue | 1 | 2026 | 11 | 0.240 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2026 | 20 | 0.240 |
Why?
|
| Myocardium | 2 | 2017 | 102 | 0.230 |
Why?
|
| Fasting | 1 | 2025 | 22 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 363 | 0.220 |
Why?
|
| Biopsy | 1 | 2025 | 188 | 0.220 |
Why?
|
| Sex Factors | 1 | 2025 | 387 | 0.210 |
Why?
|
| Glucose | 2 | 2023 | 45 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 148 | 0.190 |
Why?
|
| Halothane | 2 | 2023 | 11 | 0.190 |
Why?
|
| Caffeine | 2 | 2023 | 54 | 0.190 |
Why?
|
| Muscle Contraction | 2 | 2023 | 68 | 0.190 |
Why?
|
| Protein Isoforms | 1 | 2022 | 37 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 69 | 0.190 |
Why?
|
| Mice, Mutant Strains | 1 | 2022 | 20 | 0.180 |
Why?
|
| Male | 3 | 2026 | 12453 | 0.180 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 106 | 0.150 |
Why?
|
| Excitation Contraction Coupling | 2 | 2017 | 10 | 0.150 |
Why?
|
| Adult | 3 | 2025 | 6921 | 0.140 |
Why?
|
| Humans | 8 | 2025 | 22903 | 0.140 |
Why?
|
| Mitochondria, Muscle | 1 | 2017 | 4 | 0.130 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 55 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2018 | 462 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2017 | 107 | 0.120 |
Why?
|
| Mutation | 2 | 2015 | 328 | 0.110 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 25 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 23 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 9 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 40 | 0.100 |
Why?
|
| Cytosol | 1 | 2012 | 41 | 0.100 |
Why?
|
| Protein Binding | 1 | 2012 | 112 | 0.090 |
Why?
|
| Female | 2 | 2025 | 12934 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 526 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2024 | 60 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 23 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 11 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 19 | 0.050 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 12 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2023 | 140 | 0.050 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.040 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 130 | 0.040 |
Why?
|
| Risk Factors | 1 | 2025 | 1971 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 12 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 313 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 2017 | 3 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 387 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 89 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 260 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 262 | 0.030 |
Why?
|
| Rana pipiens | 1 | 2012 | 51 | 0.020 |
Why?
|
| Magnesium | 1 | 2012 | 36 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7435 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 7911 | 0.020 |
Why?
|